Qiagen N.V. is a Dutch healthcare company.
Qiagen N.V. (QGEN) is expected to report earnings on Tuesday, November 3, 2026, after the close. Consensus EPS estimate is $0.62.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-07 | FY2026 Q2 | $0.60 | $0.50 | -16.4% | $535.04M |
| 2026-05-08 | FY2026 Q1 | $0.54 | $0.54 | -0.4% | $492.32M |
| 2026-03-20 | FY2025 Q4 | — | $0.52 | — | $540.42M |
| 2025-11-06 | FY2025 Q3 | $0.61 | $0.60 | -1.6% | $532.58M |
| 2025-08-21 | FY2025 Q2 | — | $0.44 | — | $533.54M |
| 2025-05-13 | FY2025 Q1 | $0.50 | $0.42 | -16.5% | $483.46M |
| 2025-02-07 | FY2024 Q4 | $0.60 | $0.64 | +6.7% | $521.20M |
| 2024-11-08 | FY2024 Q3 | $0.54 | $0.44 | -18.5% | $501.87M |
QGEN has beaten consensus EPS in 1 of its last 8 reported quarters.
QGEN pays a semi-annual dividend, currently yielding 6.82%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-07-07 | $0.35 | 2026-07-14 |
| 2026-01-08 | $2.29 | - |
| 2025-07-02 | $0.25 | 2025-07-10 |
| 2025-01-29 | $1.26 | 2025-01-29 |
| 2024-01-30 | $1.28 | 2024-01-31 |
| 2017-01-25 | $1.04 | - |